Gene · 252995
Papers4,118
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
401 to 420 of 4,118
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Polypeptides synthesized by common bacteria in the human gut improve rodent metabolism. | Nat Microbiol | 2025 | 40745048 | PubTator, text mining | PubMed |
| Sarcopenia and cardiovascular disease among adults with cardiovascular-kidney-metabolic syndrome stages 0-3: A prospective cohort study. | Am J Prev Cardiol | 2025 | 40741448 | PubTator, text mining | PubMed |
| Pharmacological mechanisms and potential clinical applications of Dihydromyricetin in neurological disorders. | Front Pharmacol | 2025 | 40740995 | PubTator, text mining | PubMed |
| Association of serum urea-to-creatinine and creatinine-to-cystatin C ratios with bone mineral density and osteoporosis: a cross-sectional study. | Sci Rep | 2025 | 40739314 | PubTator, text mining | PubMed |
| The acute response of irisin to resistance and endurance exercise at both lower and higher intensities in healthy older adults. | Exp Gerontol | 2025 | 40738363 | PubTator, text mining | PubMed |
| Irisin Concentrations in Children and Adolescent Cancer Survivors and Their Relation to Metabolic, Bone, and Reproductive Profile: A Pilot Case-Control Study. | J Clin Med | 2025 | 40725790 | PubTator, text mining | PubMed |
| Definition and diagnosis of sarcopenia: Asia-Pacific perspectives. | Osteoporos Sarcopenia | 2025 | 40718357 | PubTator, text mining | PubMed |
| Hepatic ischemia-reperfusion and mitochondrial quality control: potential therapeutic targets. | Int Immunopharmacol | 2025 | 40706212 | PubTator, text mining | PubMed |
| FNDC5 and ACOX1 as Biomarkers of Peroxisomal Activity with Contrast Outcomes in Colon Adenocarcinoma. | Biol Proced Online | 2025 | 40702462 | PubTator, text mining | PubMed |
| Association Between Irisin Level and Cognitive Function: A Systematic Review and Meta-Analysis. | Brain Behav | 2025 | 40696815 | PubTator, text mining | PubMed |
| Targeting ERRs to counteract age-related muscle atrophy associated with physical inactivity: a pilot study. | Front Physiol | 2025 | 40692696 | PubTator, text mining | PubMed |
| State-of-the-art insights into myokines as biomarkers of sarcopenia: a literature review. | Int J Physiol Pathophysiol Pharmacol | 2025 | 40687683 | PubTator, text mining | PubMed |
| The role of exercise in enhancing brain and cerebrovascular health via the bone-brain axis: implications for surgical and clinical interventions. | Int J Surg | 2025 | 40680227 | PubTator, text mining | PubMed |
| Comparative Evaluation of Serum Irisin Levels in Cancer Patients and Healthy Individuals: A Systematic Review and Meta-Analysis of Diagnostic Evidence. | Cancer Invest | 2025 | 40671578 | PubTator, text mining | PubMed |
| Effects of combined training on quality of life in individuals with overweight-related type 2 diabetes: a pilot study of correlations with metabolic, inflammatory and thermogenic markers. | Ann Med | 2025 | 40665959 | PubTator, text mining | PubMed |
| Emotional state in patients after COVID-19 in relation to comprehensive rehabilitation, Brain-Derived neurotrophic factor, Irisin levels, and selected clinical factors. | Sci Rep | 2025 | 40665009 | PubTator, text mining | PubMed |
| Irisin: Emerging Therapeutic Targets for Cognitive Impairment-Related Diseases. | Expert Rev Mol Med | 2025 | 40660735 | PubTator, text mining | PubMed |
| Irisin Prevents the Effects of Simulated Microgravity on Bone and Muscle Differentiation Markers. | FASEB Bioadv | 2025 | 40654332 | PubTator, text mining | PubMed |
| Muscle in Endocrinology: From Skeletal Muscle Hormone Regulation to Myokine Secretion and Its Implications in Endocrine-Metabolic Diseases. | J Clin Med | 2025 | 40648864 | PubTator, text mining | PubMed |
| Long-Term Obesity and Biological Aging in Young Adults. | JAMA Netw Open | 2025 | 40643913 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/252995/papers?page=21